GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Biome Australia BIO.AX · AUD

Consumer Staples · ASX · 🇦🇺 Australia

Compare

0.35

+9.37%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Biome Australia — daily ASX:BIO

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Biome Australia on TradingView ↗
Market value
A$78.3m
Last close × shares
Volume
447.7k
Shares, 9 Nov 2026
Price to earnings
20.8

About Biome Australia

Its shares trade on ASX under the ticker BIO.AX. It has been listed since 30 November 2021. In the fiscal year to 30 June 2026, it reported revenue of A$23.9m and net income of A$3.6m. At that date it held total assets of A$15.7m and shareholders' equity of A$9.4m.

Biome Australia Ltd. engages in the research, development, manufacture, and distribution of evidence-based products linking the gut and human health. The company develops, licenses, commercializes and markets evidence-based, complementary medicines, including nutraceuticals (food-based vitamins and weight management products) and live biotherapeutics (probiotics). The company markets and distributes clinically researched products developed in conjunction with its strategic partners. Its products are marketed under three brands: Activated Probiotics, Activated Nutrients and Activated X Performance. Its products are distributed through community pharmacies, independent health practitioners and online direct to consumer channels. The firm distributes its products in Australia, New Zealand and the United Kingdom. The company offers biotherapeutic products to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema and irritable bowel syndrome (IBS), through randomized double-blind placebo-controlled trails.

Figures and description from our data supplier, not checked against the company's own report.

More about Biome Australia →

Latest on Biome Australia

Our reporting

We have not reported on Biome Australia yet.

Next results

23 Feb 2027

Due on 23 Feb 2027.

Other Consumer Staples listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Biome Australia's ticker?

Biome Australia trades as BIO.AX on ASX, under ISIN AU0000184137.

What was Biome Australia's last closing price?

0.35 on 9 Nov 2026. The figure is in AUD and is never converted.

When does Biome Australia next report results?

Results are expected on 23 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.